Cintas (CTAS) Liabilities and Shareholders Equity (2010 - 2026)
Cintas (CTAS) posted Liabilities and Shareholders Equity of $10.5 billion for Q2 2026, up 2.89% sequentially from $10.2 billion in Q1 2026, and up 7.16% YoY from $9.8 billion in Q2 2025.
Cintas (CTAS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Cintas has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $10.5 billion in Q2 2026.
- Quarterly Liabilities and Shareholders Equity rose 7.16% year-over-year to $10.5 billion in Q2 2026, while the trailing twelve-month figure through May 2026 was $40.7 billion (up 7.56% YoY) and the FY2026 annual result came in at $10.5 billion, up 7.16% from the prior year.
- Liabilities and Shareholders Equity climbed to $10.5 billion in Q2 2026 per CTAS's latest filing, from $10.2 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $10.5 billion in Q2 2026 and troughed at $8.1 billion in Q2 2022.
- A 5-year average of $9.1 billion and a median of $9.0 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity dropped 2.14% in 2022, then rose 8.48% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $8.4 billion in 2022, then advanced by 4.59% to $8.8 billion in 2023, then increased by 6.27% to $9.4 billion in 2024, then climbed by 8.18% to $10.1 billion in 2025, then climbed by 3.91% to $10.5 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $10.5 billion, $10.2 billion, and $10.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn | 10.53 Bn |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - | 19.63 Bn |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn | 9.65 Bn |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn | 63.57 Bn |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn | 12.49 Bn |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn | 13.97 Bn |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn | 3.12 Bn |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - | - |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn | 3.16 Bn |
| 10 | Unifirst | 5.24 Bn | 5.07 Bn | 234.73 Mn | 2.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 10.53 Bn |
| Feb 28, 2026 | 10.23 Bn |
| Nov 30, 2025 | 10.13 Bn |
| Aug 31, 2025 | 9.84 Bn |
| May 31, 2025 | 9.83 Bn |
| Feb 28, 2025 | 9.61 Bn |
| Nov 30, 2024 | 9.37 Bn |
| Aug 31, 2024 | 9.07 Bn |
| May 31, 2024 | 9.17 Bn |
| Feb 29, 2024 | 8.98 Bn |
| Nov 30, 2023 | 8.81 Bn |
| Aug 31, 2023 | 8.72 Bn |
| May 31, 2023 | 8.55 Bn |
| Feb 28, 2023 | 8.47 Bn |
| Nov 30, 2022 | 8.43 Bn |
| Aug 31, 2022 | 8.26 Bn |
| May 31, 2022 | 8.15 Bn |
| Feb 28, 2022 | 8.17 Bn |
| Nov 30, 2021 | 8.02 Bn |
| Aug 31, 2021 | 7.86 Bn |